PRTA

Biotechnology BMY BMYMP CELG.RT NONOF NOVO:CA NVO NVON:CA PRTA RHHBF RHHBY RHHVF ROCH:CA ROG:CA Terry Chrisomalis Uncategorized

Prothena: A Hold With 2 Late-Stage Programs Underway But With Caution

Mar 3, 2026

Biotechnology PRTA Uncategorized

Prothena authorizes up to $100 million share repurchase plan

Feb 27, 2026